Publications

  1. Cortes P, Kumbhari V, Antwi SO, Wallace MB, Raimondo M, Ji B, Bi Y. Simple risk score to predict the likelihood of a positive EUS in idiopathic acute pancreatitis. Gastrointest Endosc. 2022 Dec; 96 (6):993-1001.e5 Epub 2022 July 16
    View PubMed
  2. Sun P, Antwi SO, Sartorius K, Zheng X, Li X. Tumor Microenvironment, Clinical Features, and Advances in Therapy for Bone Metastasis in Gastric Cancer. Cancers (Basel). 2022 Oct 6; 14 (19) Epub 2022 Oct 06
    View PubMed
  3. Nasereldin DS, White LJ, Hodge DO, Roberts LR, Patel T, Antwi SO. Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk. Dig Liver Dis. 2022 Jul; 54 (7):964-972 Epub 2021 Dec 23
    View PubMed
  4. Steck SE, Su LJ, Antwi SO, Morris BB, Crawford B, Adams SA, Hebert JR, Fontham ETH, Bensen JT, Mohler JL, Arab L. Recreational and occupational physical activity in relation to prostate cancer aggressiveness: the North Carolina-Louisiana Prostate Cancer Project (PCaP). Cancer Causes Control. 2022 Jun; 33 (6):875-887 Epub 2022 Mar 23
    View PubMed
  5. Antwi SO, Rabe KG, Bamlet WR, Meyer M, Chandra S, Fagan SE, Hu C, Couch FJ, McWilliams RR, Oberg AL, Petersen GM. Influence of Cancer Susceptibility Gene Mutations and ABO Blood Group of Pancreatic Cancer Probands on Concomitant Risk to First-Degree Relatives. Cancer Epidemiol Biomarkers Prev. 2022 Feb; 31 (2):372-381 Epub 2021 Nov 15
    View PubMed
  6. Thomas J, Liao LM, Sinha R, Patel T, Antwi SO. Hepatocellular Carcinoma Risk Prediction in the NIH-AARP Diet and Health Study Cohort: A Machine Learning Approach. J Hepatocell Carcinoma. 2022; 9:69-81 Epub 2022 Feb 15
    View PubMed
  7. Ledenko M, Antwi SO, Arima S, Driscoll J, Furuse J, Klumpen HJ, Larsen FO, Lau DK, Maderer A, Markussen A, Moehler M, Nooijen LE, Shaib WL, Tebbutt NC, Andre T, Ueno M, Woodford R, Yoo C, Zalupski MM, Patel T. Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials. Front Oncol. 2022; 12:963753 Epub 2022 Aug 11
    View PubMed
  8. Sartorius K, Antwi SO, Chuturgoon A, Roberts LR, Kramvis A. RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality? Front Oncol. 2022; 12:891812 Epub 2022 May 04
    View PubMed
  9. Nartey YA, Antwi SO, Bockarie AS, Hiebert L, Njuguna H, Ward JW, Awuku YA, Plymoth A, Roberts LR. Mortality burden due to liver cirrhosis and hepatocellular carcinoma in Ghana; prevalence of risk factors and predictors of poor in-hospital survival. PLoS One. 2022; 17 (9):e0274544 Epub 2022 Sept 13
    View PubMed
  10. Kroner PT, Wallace MB, Raimondo M, Antwi SO, Ma Y, Li Z, Ji B, Bi Y. Systemic anticoagulation is associated with decreased mortality and morbidity in acute pancreatitis. Pancreatology. 2021 Dec; 21 (8):1428-1433 Epub 2021 Sept 08
    View PubMed
  11. ReFaey K, Tripathi S, Grewal SS, Bhargav AG, Quinones DJ, Chaichana KL, Antwi SO, Cooper LT, Meyer FB, Dronca RS, Diasio RB, Quinones-Hinojosa A. Cancer Mortality Rates Increasing vs Cardiovascular Disease Mortality Decreasing in the World: Future Implications. Mayo Clin Proc Innov Qual Outcomes. 2021 Jun; 5 (3):645-653 Epub 2021 June 08
    View PubMed
  12. Antwi SO, Bamlet WR, Cawthon RM, Rabe KG, Druliner KG, Sicotte BR, Jatoi H, Mahipal A, Boardman A, Oberg LA, Petersen AL. Shorter Treatment-Naive Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2021 Jan; 30 (1):210-216 Epub 2020 Nov 13
    View PubMed
  13. Wongjarupong N, Yonli AT, Nagalo BM, Djigma FW, Somda SK, Hassan MA, Mohamed EA, Sorgho AP, Compaore TR, Soubeiga ST, Kiendrebeogo I, Sanou M, Diarra B, Yang HI, Chen CJ, Ouattara AK, Zohoncon TM, Martinson JJ, Buetow K, Chamcheu JC, Antwi SO, Borad MJ, Simpore J, Roberts LR. Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina Faso. Hepatol Commun. 2020 Dec; 4 (12):1781-1792 Epub 2020 Sept 15
    View PubMed
  14. Ghoneim DH, Zhu J, Zheng W, Long J, Murff HJ, Ye F, Setiawan VW, Wilkens LR, Khankari NK, Haycock P, Antwi SO, Yang Y, Arslan AA, Beane Freeman LE, Bracci PM, Canzian F, Du M, Gallinger S, Giles GG, Goodman PJ, Kooperberg C, Le Marchand L, Neale RE, Scelo G, Visvanathan K, White E, Albanes D, Amiano P, Andreotti G, Babic A, Bamlet WR, Berndt SI, Brais LK, Brennan P, Bueno-de-Mesquita B, Buring JE, Campbell PT, Rabe KG, Chanock SJ, Duggal P, Fuchs CS, Gaziano JM, Goggins MG, Hackert T, Hassan MM, Helzlsouer KJ, Holly EA, Hoover RN, Katske V, Kurtz RC, Lee IM, Malats N, Milne RL, Murphy N, Oberg AL, Porta M, Rothman N, Sesso HD, Silverman DT, Thompson IM Jr, Wactawski-Wende J, Wang X, Wentzensen N, Yu H, Zeleniuch-Jacquotte A, Yu K, Wolpin BM, Jacobs EJ, Duell EJ, Risch HA, Petersen GM, Amundadottir LT, Kraft P, Klein AP, Stolzenberg-Solomon RZ, Shu XO, Wu L. Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2020 Dec; 29 (12):2735-2739 Epub 2020 Sept 23
    View PubMed
  15. Antwi SO, Petrick JL, Campbell PT, Norez DA, Stevens VL, Liao LM, Roberts LR, Patel T, McGlynn KA. One-carbon metabolism-related micronutrients intake and risk for hepatocellular carcinoma: A prospective cohort study. Int J Cancer. 2020 Oct 15; 147 (8):2075-2090 Epub 2020 Apr 25
    View PubMed
  16. Lavu S, Therneau TM, Harmsen WS, Mara KC, Wongjarupong N, Hassan M, Ali HA, Antwi S, Giama NH, Miyabe K, Roberts LR. Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma. Hepatology. 2020 Oct; 72 (4):1298-1309 Epub 2020 Oct 09
    View PubMed
  17. Antwi SO, Bamlet WR, Rabe KG, Cawthon RM, Umudi I, Druliner BR, Sicotte H, Oberg AL, Jatoi A, Boardman LA, Petersen GM. Leukocyte Telomere Length and Its Interaction with Germline Variation in Telomere-Related Genes in Relation to Pancreatic Adenocarcinoma Risk. Cancer Epidemiol Biomarkers Prev. 2020 Jul; 29 (7):1492-1500 Epub 2020 Apr 20
    View PubMed
  18. Antwi SO, Li Z, Mody K, Roberts LR, Patel T. Independent and Joint Use of Statins and Metformin by Elderly Patients With Diabetes and Overall Survival Following HCC Diagnosis. J Clin Gastroenterol. 2020 May/Jun; 54 (5):468-476
    View PubMed
  19. Antwi SO, Van Houten HK, Sangaralingham LR, Patel T. Risk of De Novo Hepatocellular Carcinoma Following Use of Direct Acting Antiviral Medications for Treatment of Chronic Hepatitis C. Cancer Prev Res (Phila). 2019 Dec; 12 (12):891-902 Epub 2019 Aug 26
    View PubMed
  20. Park JY, Luu HN, Park HY, Lin HY, Radlein S, Di Pietro G, Yeo CD, Kim SJ, Kang N, Antwi S, Sexton WJ, Spiess PE, Dickinson S, Park A. Telomere length in peripheral blood leukocytes and risk of renal cell carcinoma Translational Cancer Research. 2019 Jul; 8 (Suppl 4):S391-7
  21. Park JY, Luu HN, Park HY, Lin HY, Radlein S, Di Pietro G, Yeo CD, Kim SJ, Kang N, Antwi S, Sexton WJ, Spiess PE, Dickinson S, Parker A. Telomere length in peripheral blood leukocytes and risk of renal cell carcinoma. Transl Cancer Res. 2019 Jul; 8 (Suppl 4):S397-S403
    View PubMed
  22. Antwi SO, Fagan SE, Chaffee KG, Bamlet WR, Hu C, Polley EC, Hart SN, Shimelis H, Lilyquist J, Gnanaolivu RD, McWilliams RR, Oberg AL, Couch FJ, Petersen GM. Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status. J Natl Cancer Inst. 2019 Mar 1; 111 (3):264-271
    View PubMed
  23. Hlady RA, Zhao X, Pan X, Yang JD, Ahmed F, Antwi SO, Giama NH, Patel T, Roberts LR, Liu C, Robertson KD. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA. Theranostics. 2019; 9 (24):7239-7250 Epub 2019 Sept 25
    View PubMed
  24. Mody K, Antwi SO, Hodge DO, Ailawadhi S, Roberts L, Bekaii-Saab T. A SEER-based multi-ethnic picture of advanced intrahepatic cholangiocarcinoma in the United States pre- and post-the advent of gemcitabine/cisplatin. J Gastrointest Oncol. 2018 Dec; 9 (6):1063-1073
    View PubMed
  25. Antwi SO, Habboush YY, Chase LA, Lee DD, Patel T. Response to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma. Ann Hepatol. 2018 Nov - Dec; 17 (6):969-979
    View PubMed
  26. McWilliams RR, Wieben ED, Chaffee KG, Antwi SO, Raskin L, Olopade OI, Li D, Highsmith WE Jr, Colon-Otero G, Khanna LG, Permuth JB, Olson JE, Frucht H, Genkinger J, Zheng W, Blot WJ, Wu L, Almada LL, Fernandez-Zapico ME, Sicotte H, Pedersen KS, Petersen GM. CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations. Cancer Epidemiol Biomarkers Prev. 2018 Nov; 27 (11):1364-1370 Epub 2018 July 23
    View PubMed
  27. Antwi SO, Habboush YY, Chase LA, Lee DD, Patel T. Response to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma. Ann Hepatol. 2018 Oct 16; 17 (6):969-979
    View PubMed
  28. Antwi SO, Bamlet WR, Pedersen KS, Chaffee KG, Risch HA, Shivappa N, Steck SE, Anderson KE, Bracci PM, Polesel J, Serraino D, La Vecchia C, Bosetti C, Li D, Oberg AL, Arslan AA, Albanes D, Duell EJ, Huybrechts I, Amundadottir LT, Hoover R, Mannisto S, Chanock SJ, Zheng W, Shu XO, Stepien M, Canzian F, Bueno-de-Mesquita B, Quiros JR, Zeleniuch-Jacquotte A, Bruinsma F, Milne RL, Giles GG, Hebert JR, Stolzenberg-Solomon RZ, Petersen GM. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study. Carcinogenesis. 2018 Jul 30; 39 (8):1056-1067
    View PubMed
  29. Hu C, Hart SN, Polley EC, Gnanaolivu R, Shimelis H, Lee KY, Lilyquist J, Na J, Moore R, Antwi SO, Bamlet WR, Chaffee KG, DiCarlo J, Wu Z, Samara R, Kasi PM, McWilliams RR, Petersen GM, Couch FJ. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer. JAMA. 2018 Jun 19; 319 (23):2401-2409
    View PubMed
  30. Zheng J, Merchant AT, Wirth MD, Zhang J, Antwi SO, Shoaibi A, Shivappa N, Stolzenberg-Solomon RZ, Hebert JR, Steck SE. Inflammatory potential of diet and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Int J Cancer. 2018 Jun 15; 142 (12):2461-2470 Epub 2018 Feb 02
    View PubMed
  31. Antwi SO, Mousa OY, Patel T. Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014. Ann Hepatol. 2018 Mar 1; 17 (2):274-285
    View PubMed
  32. Antwi SO, Petersen GM. Leukocyte Telomere Length and Pancreatic Cancer Risk: Updated Epidemiologic Review. Pancreas. 2018 Mar; 47 (3):265-271
    View PubMed
  33. Antwi SO, Eckel-Passow JE, Diehl ND, Serie DJ, Custer KM, Wu KJ, Cheville JC, Thiel DD, Leibovich BC, Parker AS. Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma. Int J Cancer. 2018 Feb 15; 142 (4):747-756 Epub 2017 Oct 28
    View PubMed
  34. Antwi SO, Eckel-Passow JE, Diehl ND, Serie DJ, Custer KM, Arnold ML, Wu KJ, Cheville JC, Thiel DD, Leibovich BC, Parker AS. Coffee consumption and risk of renal cell carcinoma. Cancer Causes Control. 2017 Aug; 28 (8):857-866 Epub 2017 June 24
    View PubMed
  35. Antwi SO, Bamlet WR, Broderick BT, Chaffee KG, Oberg A, Jatoi A, Boardman LA, Petersen GM. Genetically Predicted Telomere Length is not Associated with Pancreatic Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2017 Jun; 26 (6):971-974 Epub 2017 Mar 06
    View PubMed
  36. Antwi SO, Steck SE, Su LJ, Hebert JR, Zhang H, Craft NE, Fontham ET, Smith GJ, Bensen JT, Mohler JL, Arab L. Carotenoid intake and adipose tissue carotenoid levels in relation to prostate cancer aggressiveness among African-American and European-American men in the North Carolina-Louisiana prostate cancer project (PCaP). Prostate. 2016 Sep; 76 (12):1053-66 Epub 2016 June 08
    View PubMed
  37. Antwi SO, Oberg AL, Shivappa N, Bamlet WR, Chaffee KG, Steck SE, Hebert JR, Petersen GM. Pancreatic cancer: associations of inflammatory potential of diet, cigarette smoking and long-standing diabetes. Carcinogenesis. 2016 May; 37 (5):481-90 Epub 2016 Feb 12
    View PubMed
  38. Antwi SO, Eckert EC, Sabaque CV, Leof ER, Hawthorne KM, Bamlet WR, Chaffee KG, Oberg AL, Petersen GM. Exposure to environmental chemicals and heavy metals, and risk of pancreatic cancer. Cancer Causes Control. 2015 Nov; 26 (11):1583-91 Epub 2015 Aug 21
    View PubMed
  39. Antwi SO, Steck SE, Zhang H, Stumm L, Zhang J, Hurley TG, Hebert JR. Plasma carotenoids and tocopherols in relation to prostate-specific antigen (PSA) levels among men with biochemical recurrence of prostate cancer. Cancer Epidemiol. 2015 Oct; 39 (5):752-62 Epub 2015 July 09
    View PubMed
  40. Antwi SO, Steck SE, Su LJ, Hebert JR, Zhang H, Fontham ET, Smith GJ, Bensen JT, Mohler JL, Arab L. Dietary, supplement, and adipose tissue tocopherol levels in relation to prostate cancer aggressiveness among African and European Americans: The North Carolina-Louisiana Prostate Cancer Project (PCaP). Prostate. 2015 Sep; 75 (13):1419-35 Epub 2015 June 05
    View PubMed
  41. Antwi S, Everson TM. Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at diagnosis: A population-based, propensity score analysis. Cancer Epidemiol. 2014 Aug; 38: (4)435-41.
    View PubMed
  42. Steck SE, Butler LM, Keku T, Antwi S, Galanko J, Sandler RS, Hu JJ. Nucleotide excision repair gene polymorphisms, meat intake and colon cancer risk. Mutat Res. 2014 Apr; 762:24-31.
    View PubMed
  43. Antwi S, Steck SE, Heidari K. Association between prevalence of chronic obstructive pulmonary disease and health-related quality of life, South Carolina, 2011. Prev Chronic Dis. 2013 Dec 26; 10:E215.
    View PubMed
  44. Antwi S, Tucker TC, Coker AL, Fleming ST. Racial disparities in survival after diagnosis of prostate cancer in Kentucky, 2001-2010. Am J Mens Health. 2013 Jul; 7: (4)306-16.
    View PubMed